Skip to main content Back to Top
Advertisement

2/9/2021

Norepinephrine Bitartrate Injection

Products Affected - Description

    • Levophed injection, Pfizer, 1 mg/mL, 4 mL ampule, 10 count, NDC 00409-1143-04 - discontinued
    • Levophed injection, Pfizer, 1 mg/mL, 4 mL vial, 10 count, NDC 00409-3375-04
    • Norepinephrine injection, Hikma, 1 mg/mL, 4 mL vial, 10 count, NDC 00143-9318-10
    • Norepinephrine injection, Mylan Institutional, 1 mg/mL, 4 mL vial, 10 count, NDC 67457-0852-04

Reason for the Shortage

    • Baxter has norepinephrine injection available.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.
    • Pfizer has Levophed vials on shortage due to increased demand.
    • Teva has norepinephrine injection available.

Available Products

    • Norepinephrine injection, Baxter, 1 mg/mL, 4 mL ampule, 10 count, NDC 36000-0162-10
    • Norepinephrine injection, Teva, 1 mg/mL, 4 mL vial, 10 count, NDC 00703-1153-03

Estimated Resupply Dates

    • Hikma has norepinephrine 1 mg/mL 4 mL vials available with short expiration dating (< October 2021).
    • Mylan has norepinephrine 1 mg/mL 4 ml vials on back order and the company estimates a release date in mid-February 2021.
    • Pfizer has Levophed 1 mg/mL 4 mL vials on back order and the company estimates a release date in April 2021.

Updated

Updated February 9, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 22, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.